349 related articles for article (PubMed ID: 32874054)
21. Securing wider EU commitment to the elimination of hepatitis C virus.
Wedemeyer H; Tergast TL; Lazarus JV; Razavi H; Bakoyannis K; Baptista-Leite R; Bartoli M; Bruggmann P; Buşoi CS; Buti M; Carballo M; Castera L; Colombo M; Coutinho RS; Dadon Y; Esmat G; Esteban R; Farran JC; Gillyon-Powell M; Goldberg D; Hutchinson S; Janssen HLA; Kalamitsis G; Kondili LA; Lambert JS; Marinho RT; Maticic M; Patricello A; Peck-Radosavljevic M; Pol S; Poljak M; Pop C; Sokol T; Sypsa V; Tözün N; Younossi Z; Aghemo A; Papatheodoridis GV; Hatzakis A
Liver Int; 2023 Feb; 43(2):276-291. PubMed ID: 36196744
[TBL] [Abstract][Full Text] [Related]
22. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
[TBL] [Abstract][Full Text] [Related]
23. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.
Doyle JS; Scott N; Sacks-Davis R; Pedrana AE; Thompson AJ; Hellard ME;
Aliment Pharmacol Ther; 2019 May; 49(9):1223-1229. PubMed ID: 30908706
[TBL] [Abstract][Full Text] [Related]
24. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
25. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
26. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
27. Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States.
McNamara M; Furukawa N; Cartwright EJ
Emerg Infect Dis; 2024 Apr; 30(13):S80-S87. PubMed ID: 38561831
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C Elimination: Opportunities and Challenges in 2023.
Taha G; Ezra L; Abu-Freha N
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515101
[TBL] [Abstract][Full Text] [Related]
29. A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project.
Dröse S; Øvrehus ALH; Holm DK; Madsen LW; Mössner BK; Søholm J; Hansen JF; Røge BT; Christensen PB
BMC Infect Dis; 2022 Mar; 22(1):202. PubMed ID: 35232372
[TBL] [Abstract][Full Text] [Related]
30. Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).
Huang JF; Hsieh MY; Wei YJ; Hung JY; Huang HT; Huang CI; Yeh ML; Huang CF; Jang TY; Hsu PY; Liang PC; Dai CY; Lin ZY; Yu ML; Chuang WL
Hepatol Int; 2022 Feb; 16(1):59-67. PubMed ID: 34850326
[TBL] [Abstract][Full Text] [Related]
31. Challenges on the achievement of World Health Organization goals for HCV elimination in Italy: need for a Regional programmatic approach on screening and linkage to care. Commentary.
Kondili LA; Aghemo A; Andreoni M
Ann Ist Super Sanita; 2021; 57(3):201-204. PubMed ID: 34554113
[TBL] [Abstract][Full Text] [Related]
32. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
33. Is elimination of hepatitis C virus realistic by 2030: Eastern Europe.
Isakov V; Tsyrkunov V; Nikityuk D
Liver Int; 2021 Jun; 41 Suppl 1():50-55. PubMed ID: 34155800
[TBL] [Abstract][Full Text] [Related]
34. The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.
Popping S; Bade D; Boucher C; van der Valk M; El-Sayed M; Sigurour O; Sypsa V; Morgan T; Gamkrelidze A; Mukabatsinda C; Deuffic-Burban S; Ninburg M; Feld J; Hellard M; Ward J
J Virus Erad; 2019 Jan; 5(1):60-66. PubMed ID: 30800429
[TBL] [Abstract][Full Text] [Related]
35. The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.
Safreed-Harmon K; Blach S; Aleman S; Bollerup S; Cooke G; Dalgard O; Dillon JF; Dore GJ; Duberg AS; Grebely J; Boe Kielland K; Midgard H; Porter K; Razavi H; Tyndall M; Weis N; Lazarus JV
Clin Infect Dis; 2019 Nov; 69(12):2218-2227. PubMed ID: 31352481
[TBL] [Abstract][Full Text] [Related]
36. Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care.
Lazarus JV; Herranz A; Picchio CA; Villota-Rivas M; Rodríguez A; Alonso JM; Moratinos A; Perrotta A; Tegeo E; Bibiloni F; Buti M; Vilella À
BMJ Open; 2021 Oct; 11(10):e053394. PubMed ID: 34675021
[TBL] [Abstract][Full Text] [Related]
37. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C prevalence and elimination planning in Pakistan, a bottom-up approach accounting for provincial variation.
Mooneyhan E; Qureshi H; Mahmood H; Tariq M; Maqbool NA; Anwar M; Aslam M; Azam F; Blach S; Khan AG; Hamid S; Hussain T; Akhter MK; Khan A; Khan U; Khowaja S; Mahmood K; Mazhar S; Nawaz A; Rose A; Ghorezai GSA; Shah S; Sarwar SZ; Razavi H
J Viral Hepat; 2023 Apr; 30(4):345-354. PubMed ID: 36650932
[TBL] [Abstract][Full Text] [Related]
39. [In-hospital process for viral hepatitis C screening and management in China (Draft)].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):319-325. PubMed ID: 33979957
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]